Products found to contain undeclared medicines
|
| |
| The United States: Umary contains hidden drug ingredients |
| |
The United States Food and Drug Administration (FDA) is advising consumers not to purchase or use Umary, a product promoted and sold for pain on various websites, including https://www.solovital.com and possibly in some retail stores.
FDA laboratory analysis confirmed that Umary contains diclofenac and omeprazole, which are not listed on the product label.
Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.
Omeprazole is a proton pump inhibitor (commonly referred to as PPI) used to treat gastric (stomach) acid-related disorders. PPI medicines may cause serious skin reactions, abdominal pain, diarrhea, nausea, and headache. This hidden ingredient may mask stomach issues such as erosions, ulcers, and stomach cancer, and it can also interact with other medications and should not be taken with certain medications.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/umary-contains-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 16 May 2024.
Ends/ Saturday, June 15, 2024
Issued at HKT 13:30
|
| |
|
